Nov 20, 2020 | COVID-19, Health News, Vaccines
Qualmedica Research is currently enrolling two clinical trials focused on a new antibody therapy developed by Eli Lilly. The BLAZE 1 study is for patients 0 – 17 years old with underlying risk factors. The BLAZE 4 study is recruiting patients 12+ with...
Aug 26, 2020 | Health News, Vaccines
Before a new vaccine is ever given to people, extensive lab testing is done that can take several years. Once testing in people begins, it can take several more years before clinical studies are complete and the vaccine is approved. The FDA sets rules for the three...
Aug 18, 2020 | COVID-19, Health News, Vaccines
The COVID-19 pandemic has caused quite the fear to our community. Qualmedica Research has compiled information in a Q&A format to update you on current efforts to develop drug therapies and vaccines. We hope you find this information helpful. Who is Qualmedica...
Jul 20, 2020 | Health News
Qualmedica Research is a multi-site clinical research company offering clinical trials in Bowling Green, KY; Owensboro, KY; and Evansville, IN. We are pleased to announce our recent expansion into Bowling Green and our relationship with the doctors and staff at...
Jun 24, 2020 | Health News, Neurological Disorders
Clinical Trial for Migraines in Children Study Location(s): Owensboro and Bowling Green Kentucky, Evansville Indiana Migraine is one of the most common neurological conditions in pediatrics with a prevalence of approximately 8% in children under 20 years of age. ...
Jun 24, 2020 | Health News, Vaccines
TELL ME MORE ABOUT THIS CLINICAL TRIAL for an INFANT MENINGOCOCCAL VACCINE This is an Immunogenicity and Safety Study of a Quadrivalent Vaccine Administered Concomitantly with Routine Pediatric Vaccines in Healthy Infants and Toddlers [contact-form-7...
